AEs of any grade and of grade ≥3 in the patients included in the series
| . | Any grade . | Grade ≥3 . |
|---|---|---|
| Total number | 106 | 36 |
| No. of patients | 20/30 (67%) | 16/30 (53%) |
| Hematologic | 30 (28%) | 15/36 (42%) |
| Infectious | 8 (8%) | 6/36 (17%) |
| Gastrointestinal | 15 (14%) | 1/36 (3%) |
| Skin | 5 (5%) | 1/36 (3%) |
| Respiratory | 6 (6%) | 2/36 (6%) |
| General | 4 (4%) | — |
| Neurologic | 4 (4%) | — |
| Ocular | 2 (2%) | 2/36 (6%) |
| Hepatic | 12 (11%) | 8/36 (22%) |
| Hypertension | 1 (1%) | — |
| Vascular occlusive event | 1 (1%) | 1/36 (3%) |
| Other | 17 (16%) | — |
| . | Any grade . | Grade ≥3 . |
|---|---|---|
| Total number | 106 | 36 |
| No. of patients | 20/30 (67%) | 16/30 (53%) |
| Hematologic | 30 (28%) | 15/36 (42%) |
| Infectious | 8 (8%) | 6/36 (17%) |
| Gastrointestinal | 15 (14%) | 1/36 (3%) |
| Skin | 5 (5%) | 1/36 (3%) |
| Respiratory | 6 (6%) | 2/36 (6%) |
| General | 4 (4%) | — |
| Neurologic | 4 (4%) | — |
| Ocular | 2 (2%) | 2/36 (6%) |
| Hepatic | 12 (11%) | 8/36 (22%) |
| Hypertension | 1 (1%) | — |
| Vascular occlusive event | 1 (1%) | 1/36 (3%) |
| Other | 17 (16%) | — |